Meet 2014 CEO of the Year Honoree Jeff Baker

By ThriveAdmin | October 13, 2014
Posted in

Jeff Baker is president and CEO of Noble, which develops and makes products for the pharmaceutical and biotechnology industries, including educational tools and device training that reduces errors in drug… Read More »

Florida Fast 100

By ThriveAdmin | September 19, 2014
Posted in

NOBLE RANKS #56 AMONG FLORIDA FAST 100 AWARDS Ranked by Revenue Growth, Two-Year Percent Change (2011-2013).

Considering Human Factors And Training In Medical Device Design

By ThriveAdmin | August 7, 2014
Posted in , , , , , , , , , , ,

The patient has become the end user when it comes to many types of medical technology, and that trend is likely to continue with the rise of mobile health (mHealth),… Read More »

Noble’s Second Consecutive Fast 50 Award

By ThriveAdmin | June 27, 2014
Posted in

[fusion_builder_container hundred_percent=”no” hundred_percent_height=”no” hundred_percent_height_scroll=”no” hundred_percent_height_center_content=”yes” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” border_size=”” border_color=”” border_style=”solid”… Read More »

How to Establish Brand Preference Among HCPs

By ThriveAdmin | April 1, 2014
Posted in , , , , ,

In recent years, environmental factors have changed the way products are launched and managed throughout the lifecycle. The Sunshine & HITECH Acts, as well as the emergence of new device… Read More »

Educating Patients on Self-administered Drug Injections

By ThriveAdmin | January 1, 2014
Posted in , , , , , , ,

With the time and resources invested in developing and evaluating new drugs through clinical trials, the reality is much of a new treatment’s success is dependent on patients’ ability to… Read More »